s
Anti-idiotypic antibodies are essential reagents for PK and ADA assays to support pre-clinical and clinical trial studies for a new biologic or biosimilar.
Whether to support your regulatory applications, biosimilar development, or research studies on biologics, off-the-shelf anti-idiotypic antibodies (anti-IDs) will help you achieve your outcome faster.
Bio-Rad offers an extensive range of anti-IDs, with more than 150 products, one of the largest on the market.
The downloadable infographic highlights the ten key reasons why Bio-Rad's anti-idiotypic antibodies are market-leaders.
All our antibodies are extensively tested for suitability in their stated applications.
For example, anti-IDs for Fc-fusion biologics such as belatacept.